Synageva: Synageva Biopharma Corp Given Average Recommendation of "Hold" by Analysts (NASDAQ:GEVA)

Shares of Synageva Biopharma Corp (NASDAQ:GEVA) have earned an average rating of "Hold" from the eight analysts that are covering the company, Market Beat Ratings reports. Seven investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 12-month target price among brokers that [...]